Chemed (NYSE: CHE) holder files to sell 2,000 shares worth $1.06M

Rhea-AI Filing Summary

Chemed Corporation has a holder preparing to sell 2,000 shares of common stock through Merrill Lynch, with the shares listed on the NYSE. The planned sale has an aggregate market value of $1,064,500, compared against 13,069,961 shares outstanding.

The seller previously acquired Chemed stock through stock awards and related stock exercises, including 1,656 shares tied to a transaction dated May 2, 2023 and 344 shares tied to a transaction dated August 3, 2023.

Key Figures

Shares to be sold: 2,000 shares Aggregate market value: $1,064,500 Shares outstanding: 13,069,961 shares +2 more

5 metrics

Shares to be sold 2,000 shares Planned sale of Chemed common stock under Form 144

Aggregate market value $1,064,500 Value of the 2,000 Chemed shares planned for sale

Shares outstanding 13,069,961 shares Chemed common shares outstanding referenced in the filing

Stock award shares (May 2, 2023) 1,656 shares Chemed stock award and related exercise dated May 2, 2023

Stock award shares (August 3, 2023) 344 shares Chemed stock award and related exercise dated August 3, 2023

Key Terms

Form 144, Stock Award, Stock Exercise

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Award financial

"Common | 05/02/2023 | Stock Award | Chemed Corporation"

Stock Exercise financial

"1656 | 05/02/2023 | Stock Exercise Common | 08/03/2023"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 03:39 PM Accepted by SEC EDGAR 08/03/2026 - 03:38 PM Learn about SEC filing dates

FAQ

What does Chemed (CHE) disclose in this Form 144 filing?

The filing indicates a holder plans to sell 2,000 shares of Chemed common stock on the NYSE, with an aggregate market value of $1,064,500, using Merrill Lynch as broker.

How many Chemed (CHE) shares are planned for sale and at what value?

The planned sale covers 2,000 shares of Chemed common stock with an aggregate market value of $1,064,500, based on the pricing information referenced in the Form 144.

What is the Chemed (CHE) share count referenced in the Form 144?

The Form 144 references 13,069,961 shares outstanding of Chemed common stock. This figure provides a baseline for understanding the size of the planned 2,000-share sale.

What prior Chemed (CHE) stock awards are mentioned in this Form 144?

The disclosure lists stock awards and related exercises for 1,656 shares dated May 2, 2023 and 344 shares dated August 3, 2023, both involving Chemed common stock.

Which broker is handling the planned Chemed (CHE) share sale?

The Form 144 identifies Merrill Lynch, located at 5905 E. Galbraith Rd Suite 7000, Cincinnati, OH 45236, as the brokerage firm involved in the planned 2,000-share sale of Chemed common stock.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 5905 E. Galbraith Rd Suite 7000 Cincinnati OH 45236	2000	1064500	13069961	08/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/02/2023	Stock Award	Chemed Corporation			1656	05/02/2023	Stock Exercise
Common	08/03/2023	Stock Award	Chemed Corporation			344	08/03/2023	Stock Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)